Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Chloroquine as alternative antimalarial in systemic lupus erythematosus: response to '2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine' by Figueroa-Parra et al.

Fanouriakis A, Bertsias GK, Boumpas DT.

Ann Rheum Dis. 2019 Jun 8. pii: annrheumdis-2019-215746. doi: 10.1136/annrheumdis-2019-215746. [Epub ahead of print] No abstract available.

PMID:
31177098
2.

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.

Panousis NI, Bertsias GK, Ongen H, Gergianaki I, Tektonidou MG, Trachana M, Romano-Palumbo L, Bielser D, Howald C, Pamfil C, Fanouriakis A, Kosmara D, Repa A, Sidiropoulos P, Dermitzakis ET, Boumpas DT.

Ann Rheum Dis. 2019 Aug;78(8):1079-1089. doi: 10.1136/annrheumdis-2018-214379. Epub 2019 Jun 5.

3.

REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A).

Frangou E, Chrysanthopoulou A, Mitsios A, Kambas K, Arelaki S, Angelidou I, Arampatzioglou A, Gakiopoulou H, Bertsias GK, Verginis P, Ritis K, Boumpas DT.

Ann Rheum Dis. 2019 Feb;78(2):238-248. doi: 10.1136/annrheumdis-2018-213181. Epub 2018 Dec 18.

4.

Sexual dimorphism in SLE: above and beyond sex hormones.

Christou EAA, Banos A, Kosmara D, Bertsias GK, Boumpas DT.

Lupus. 2019 Jan;28(1):3-10. doi: 10.1177/0961203318815768. Epub 2018 Dec 1. Review.

5.

2008-2018: a decade of recommendations for systemic lupus erythematosus.

Boumpas DT, Bertsias GK, Fanouriakis A.

Ann Rheum Dis. 2018 Nov;77(11):1547-1548. doi: 10.1136/annrheumdis-2018-214014. No abstract available.

PMID:
30309872
6.

Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece.

Gergianaki I, Fanouriakis A, Repa A, Tzanakakis M, Adamichou C, Pompieri A, Spirou G, Bertsias A, Kabouraki E, Tzanakis I, Chatzi L, Sidiropoulos P, Boumpas DT, Bertsias GK.

Ann Rheum Dis. 2017 Dec;76(12):1992-2000. doi: 10.1136/annrheumdis-2017-211206. Epub 2017 Aug 5.

PMID:
28780511
7.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A.

Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25.

8.

Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4.

Krasoudaki E, Banos A, Stagakis E, Loupasakis K, Drakos E, Sinatkas V, Zampoulaki A, Papagianni A, Iliopoulos D, Boumpas DT, Bertsias GK.

Nephrol Dial Transplant. 2016 Oct;31(10):1676-86. doi: 10.1093/ndt/gfv374. Epub 2015 Nov 5.

PMID:
26546590
9.

Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation.

Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias GK, Sidiropoulos P, Boumpas DT, Verginis P.

Arthritis Rheumatol. 2016 Feb;68(2):449-61. doi: 10.1002/art.39441.

10.

Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever.

Repa A, Bertsias GK, Petraki E, Choulaki C, Vassou D, Kambas K, Boumpas DT, Goulielmos G, Sidiropoulos P.

Hum Immunol. 2015 Jul;76(7):488-95. doi: 10.1016/j.humimm.2015.06.007. Epub 2015 Jun 12.

PMID:
26074413
11.

Lupus nephritis management guidelines compared.

Wilhelmus S, Bajema IM, Bertsias GK, Boumpas DT, Gordon C, Lightstone L, Tesar V, Jayne DR.

Nephrol Dial Transplant. 2016 Jun;31(6):904-13. doi: 10.1093/ndt/gfv102. Epub 2015 Apr 28. Review.

12.

Almost half of octogenarians and nonagenarians admitted acutely to internal medicine ward die during admission or within 6 months after discharge: time to redefine treatment goals?

Perysinaki GS, Theodorakopoulou V, Bertsias A, Peteinaraki E, Tsachakis-Mueck N, Giaka M, Bertsias GK, Boumpas DT, Panagiotakis SH.

J Am Geriatr Soc. 2015 Feb;63(2):380-3. doi: 10.1111/jgs.13273. No abstract available.

PMID:
25688610
13.

Women's health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: a report from a south-eastern European Expert Meeting.

Ntali S, Damjanov N, Drakakis P, Ionescu R, Kalinova D, Rashkov R, Malamitsi-Puchner A, Mantzaris G, Michala L, Pamfil C, Rednic S, Tektonidou MG, Tsiodras S, Vassilopoulos D, Vojinovic J, Bertsias GK, Boumpas DT.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):959-68. Epub 2014 Nov 7. Review.

PMID:
25436516
14.

Steroid-induced diabetes in rheumatologic patients.

Angelopoulos TP, Tentolouris NK, Bertsias GK, Boumpas DT.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):126-30. Epub 2013 Oct 17. Review.

PMID:
24143933
15.

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival.

Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, Zisopoulos D, Skopouli FN, Iliopoulos A, Bertsias GK, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P.

Semin Arthritis Rheum. 2014 Feb;43(4):447-57. doi: 10.1016/j.semarthrit.2013.07.011. Epub 2013 Sep 6.

PMID:
24012040
16.

Gene expression and regulation in systemic lupus erythematosus.

Frangou EA, Bertsias GK, Boumpas DT.

Eur J Clin Invest. 2013 Oct;43(10):1084-96. doi: 10.1111/eci.12130. Epub 2013 Jul 31. Review.

PMID:
23902282
17.

Diagnostic criteria for systemic lupus erythematosus: has the time come?

Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT.

Nat Rev Rheumatol. 2013 Nov;9(11):687-94. doi: 10.1038/nrrheum.2013.103. Epub 2013 Jul 9. Review.

PMID:
23838616
18.

Pathogenesis and treatment of CNS lupus.

Fanouriakis A, Boumpas DT, Bertsias GK.

Curr Opin Rheumatol. 2013 Sep;25(5):577-83. doi: 10.1097/BOR.0b013e328363eaf1. Review.

PMID:
23836074
19.

WITHDRAWN: Use of mycophenolic acid in lupus nephritis.

Bertsias GK, Boumpas DT.

Clin Immunol. 2013 Jan 6. pii: S1521-6616(12)00310-5. doi: 10.1016/j.clim.2012.12.010. [Epub ahead of print]

PMID:
23375661
20.

Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.

Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, Sidiropoulos P, Boumpas DT.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):172-9. Epub 2012 Nov 6.

PMID:
23137515
21.

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association.

Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.

22.

Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.

Fanouriakis A, Boumpas DT, Bertsias GK.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):437-51. doi: 10.1586/ecp.11.23. Review.

PMID:
22114854
23.

Connective tissue diseases: Lupus nephritis-winning a few battles but not the war.

Bertsias GK, Boumpas DT.

Nat Rev Rheumatol. 2011 Jun 21;7(8):441-2. doi: 10.1038/nrrheum.2011.88. No abstract available.

PMID:
21691329
24.

An underlying systemic disease is common among patients with chronic, treatment resistant urticaria, referred to a tertiary referral centre for autoimmune diseases.

Katsikas G, Karageorgaki ZT, Bertsias GK, Spanakis E, Kritikos HD, Sidiropoulos P, Boumpas DT.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):925. Epub 2011 Jan 4. No abstract available.

PMID:
21122274
25.

A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?

Boumpas DT, Bertsias GK, Balow JE.

Ann Rheum Dis. 2010 Dec;69(12):2059-61. doi: 10.1136/ard.2010.139683. No abstract available.

26.

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.

Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT.

Ann Rheum Dis. 2010 Dec;69(12):2074-82. doi: 10.1136/ard.2010.130476. Epub 2010 Aug 19.

PMID:
20724309
27.

Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade.

Bertsias GK, Salmon JE, Boumpas DT.

Ann Rheum Dis. 2010 Sep;69(9):1603-11. doi: 10.1136/ard.2010.135186. Review.

PMID:
20699243
28.

Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Bertsias GK, Boumpas DT.

Nat Rev Rheumatol. 2010 Jun;6(6):358-67. doi: 10.1038/nrrheum.2010.62. Epub 2010 May 11. Review.

PMID:
20458332
29.

Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece.

Karageorgaki ZT, Bertsias GK, Mavragani CP, Kritikos HD, Spyropoulou-Vlachou M, Drosos AA, Boumpas DT, Moutsopoulos HM.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S33-9.

PMID:
19646344
30.

Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.

Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT.

Arthritis Rheum. 2009 Jan;60(1):207-18. doi: 10.1002/art.24227.

31.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints.

Bertsias GK, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Boumpas DT, Gordon C.

Ann Rheum Dis. 2009 Apr;68(4):477-83. doi: 10.1136/ard.2007.083030. Epub 2008 Apr 23. Review.

PMID:
18434449
32.

Toll like receptors and autoimmunity: a critical appraisal.

Papadimitraki ED, Bertsias GK, Boumpas DT.

J Autoimmun. 2007 Dec;29(4):310-8. Epub 2007 Oct 24. Review.

PMID:
17959357
33.

Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.

Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT.

Ann Rheum Dis. 2007 Jan;66(1):28-33. Epub 2006 Jun 22.

34.
35.

Review of clinical and toxicological features of acute pesticide poisonings in Crete (Greece) during the period 1991-2001.

Bertsias GK, Katonis P, Tzanakakis G, Tsatsakis AM.

Med Sci Monit. 2004 Nov;10(11):CR622-7. Epub 2004 Oct 26.

PMID:
15507854
36.

Hair analysis differentiates chronic from acute carbamazepine intoxication.

Mantzouranis EC, Bertsias GK, Pallis EG, Tsatsakis AM.

Pediatr Neurol. 2004 Jul;31(1):73-5.

PMID:
15246499
37.

Cigarette smoking, alcohol consumption, and serum lipid profile among medical students in Greece.

Mammas IN, Bertsias GK, Linardakis M, Tzanakis NE, Labadarios DN, Kafatos AG.

Eur J Public Health. 2003 Sep;13(3):278-82.

PMID:
14533734
38.

Severe fenthion intoxications due to ingestion and inhalation with survival outcome.

Tsatsakis AM, Bertsias GK, Liakou V, Mammas IN, Stiakakis I, Tzanakakis GN.

Hum Exp Toxicol. 2002 Jan;21(1):49-54.

PMID:
12046724
39.

Acute fatal poisoning by methomyl caused by inhalation and transdermal absorption.

Tsatsakis AM, Bertsias GK, Mammas IN, Stiakakis I, Georgopoulos DB.

Bull Environ Contam Toxicol. 2001 Apr;66(4):415-20. No abstract available.

PMID:
11443300

Supplemental Content

Loading ...
Support Center